Dasatinib deals to imatinib-resistant disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1621, 2008-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dasatinib: a once-daily option for imatinib-resistant CML

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Dasatinib a START-R in imatinib-resistant CML

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Dasatinib off to a good start in imatinib-resistant CML

Inpharma, Vol. 1, Iss. 1523, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Dasatinib Treatment for Imatinib Resistant or Intolerant Patients with Chronic Myeloid Leukaemia

By Li J Xu G Yu S He L Guo L

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 337-347

Field House Publishing

Access to resources Recommend Favorite

Dasatinib/imatinib: Monosomy 7: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite